We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current SGMT market cap is 81.65M. The company's latest EPS is USD -1.3041 and P/E is -2.98.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Total Revenue | 0 | 0 | 2M | 0 | 0 |
| Operating Income | -6.77M | -7.06M | -7.45M | -9.47M | -8.77M |
| Net Income | -6.59M | -6.79M | -6.35M | -8.15M | -6.63M |
| Year End December 30 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 2M |
| Operating Income | -23.72M | -31.06M | -30.74M |
| Net Income | -24.44M | -30.5M | -27.88M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Total Assets | 27.25M | 21.5M | 102.93M | 96.72M | 194.53M |
| Total Liabilities | 5.33M | 5.29M | 5.05M | 5.65M | 4.51M |
| Total Equity | -192.7M | -198.41M | 97.88M | 91.07M | 190.02M |
| Year End December 30 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 59.03M | 33.03M | 96.72M |
| Total Liabilities | 2.67M | 5.36M | 5.65M |
| Total Equity | -158.26M | -186.95M | 91.07M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Operating | -7.08M | -12.8M | -16.68M | -23.77M | -6.21M |
| Investing | 19.4M | 32.2M | 32.2M | 12.58M | 3M |
| Financing | -136k | -1.05M | 86.17M | 86.17M | 104.85M |
| Year End December 30 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Operating | -21.71M | -24.49M | -23.77M |
| Investing | N/A | -32.01M | 12.58M |
| Financing | 9.74M | -73k | 86.17M |
| Market Cap | 81.65M |
| Price to Earnings Ratio | -2.98 |
| Price to Sales Ratio | 41.45 |
| Price to Cash Ratio | 1.1 |
| Price to Book Ratio | 0.91 |
| Dividend Yield | - |
| Shares Outstanding | 21.38M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.07 (1.76%) |
| Company Name | Sagiment Biosciences Inc |
| Address |
2140 south dupont highway camden, delaware 19934 |
| Website | https:// |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
